NASDAQ:CPIX Cumberland Pharmaceuticals (CPIX) Stock Price, News & Analysis $1.79 -0.11 (-5.78%) (As of 12/29/2023 ET) Add Compare Share Share Today's Range$1.72▼$1.9050-Day Range$1.60▼$2.0952-Week Range$1.43▼$2.91Volume13,134 shsAverage Volume11,710 shsMarket Capitalization$26.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media About Cumberland Pharmaceuticals Stock (NASDAQ:CPIX)Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It also develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases; and a product candidate for cholesterol reducing agent to use in the hospital setting. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.Read More CPIX Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CPIX Stock News HeadlinesDecember 31, 2023 | msn.comInjuries reported following crash on I-81 in Cumberland CountyDecember 31, 2023 | msn.comCumberland defeats Lincoln in boarder battle 10-4December 31, 2023 | MarketBeat Internal (Ad)MarketBeat All Access New Year's Sale - Just $1.00Access our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Save 75% Your 2024 Subscription. Just $1.00 for the first 30 days.December 30, 2023 | msn.comMulti-vehicle crash shut down Cumberland County roadDecember 30, 2023 | msn.comCumberland charity heroes raise vital funds in 2023December 29, 2023 | news.yahoo.comCumberland Piano Trio to perform Jan. 14 in Oak RidgeDecember 29, 2023 | news.yahoo.comCumberland's canine castaway: Dog rescued from island by fire department and animal controlDecember 29, 2023 | msn.comMaryland State Fire Marshal investigating intentional trash can fires in CumberlandDecember 31, 2023 | MarketBeat Internal (Ad)New Year's Sale: Get MarketBeat All Access Free For 30 DaysAccess our premier research platform that includes MarketBeat Daily Premium, portfolio monitoring tools, stock screeners, research tools, a real-time news feed, email and SMS alerts, the MarketBeat Idea Engine, proprietary brokerage rankings, extended data export tools and much more. Click the link to claim your $300.00 account credit and free 30-day subscriptionDecember 29, 2023 | msn.comCumberland crews rescue dog stranded on island at Rawson PondDecember 29, 2023 | msn.comWinter weather advisory issued for Cumberland Plateau; rest of Middle Tennessee to see flurries, snow showersDecember 29, 2023 | msn.comSearch underway for missing Cumberland County 15-year-oldDecember 29, 2023 | msn.comAnimal control officers, firefighters and neighbors rescue dog from Cumberland pondDecember 29, 2023 | msn.comCumberland's canine castaway: Dog rescued from island by Cumberland fire departmentDecember 28, 2023 | msn.comNeighbors and crews rescue dog from Cumberland pondDecember 28, 2023 | nj.comSchalick/Cumberland takes team title at 2023 Clipper Classic - Wrestling recapDecember 28, 2023 | msn.comCrash causing delays on I-81 in Cumberland CountyDecember 28, 2023 | msn.comFlood warning issued as Cape Fear River rises in Cumberland, Bladen countiesDecember 28, 2023 | msn.comMan robs Cumberland County bank, police sayDecember 28, 2023 | msn.comPair sentenced for fatal fentanyl delivery in Cumberland CountyDecember 28, 2023 | news.yahoo.comPolice urge public to ignore fake news story about deadly shooting in Cumberland CountyDecember 27, 2023 | msn.comHarrisburg man sentenced for Cumberland County double stabbingDecember 27, 2023 | msn.comCumberland has lowest rate of homelessness in the UK this ChristmasDecember 27, 2023 | msn.com35-year-old man fatally shot in Cumberland; 'person of interest' in custodyDecember 27, 2023 | msn.comCumberland PD investigates after man found dead in home, ‘person of interest’ in custodyDecember 26, 2023 | msn.comScam caller falsely impersonating sheriff, Cumberland County Sheriff’s Office saysDecember 26, 2023 | msn.com2 fishermen treated for hypothermia after falling into Lake CumberlandSee More Headlines Receive CPIX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cumberland Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/07/2023Today12/31/2023Fiscal Year End12/31/2023Next Earnings (Estimated)3/05/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Pharmaceutical preparations Sub-IndustryPharmaceuticals SectorMedical Current SymbolNASDAQ:CPIX CUSIP23077010 CIK1087294 Webwww.cumberlandpharma.com Phone(615) 255-0068Fax615-255-0094Employees85Year Founded1999Profitability EPS (Most Recent Fiscal Year)($0.17) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,570,000.00 Net Margins-6.17% Pretax Margin-6.15% Return on Equity8.68% Return on Assets3.49% Debt Debt-to-Equity Ratio0.36 Current Ratio1.53 Quick Ratio1.21 Sales & Book Value Annual Sales$39.32 million Price / Sales0.68 Cash Flow$0.47 per share Price / Cash Flow3.79 Book Value$2.45 per share Price / Book0.73Miscellaneous Outstanding Shares14,905,000Free Float8,634,000Market Cap$26.71 million OptionableOptionable Beta0.13 Social Links Ten Starter Stocks For Beginners to Buy NowJust getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.Get This Free Report Key ExecutivesMr. A. J. Kazimi MBA (Age 65)Founder, Chairman, President & CEO Comp: $897.5kMr. John Michael Hamm (Age 67)Chief Financial Officer Comp: $231.38kMr. James Lowrance Herman (Age 68)Executive VP of National Accounts & Chief Compliance Officer Comp: $352.65kMs. Jean W. Marstiller (Age 73)Senior VP of Administrative Services & Corporate Secretary Comp: $282.17kMr. Chris T. Bitterman (Age 58)Vice President of Sales & Marketing Mr. Adam S. Mostafa (Age 43)Managing Director Mr. Todd M. Anthony (Age 62)Vice President of Organizational Development Ms. Erin Smith GullSenior Corporate Relations AssociateMore ExecutivesKey CompetitorsAssembly BiosciencesNASDAQ:ASMBNektar TherapeuticsNASDAQ:NKTRRegulus TherapeuticsNASDAQ:RGLSTherapeuticsMDNASDAQ:TXMDForte BiosciencesNASDAQ:FBRXView All CompetitorsInstitutional OwnershipBank of New York Mellon CorpBought 75,268 shares on 10/24/2023Ownership: 0.524%View All Institutional Transactions CPIX Stock Analysis - Frequently Asked Questions How have CPIX shares performed in 2023? Cumberland Pharmaceuticals' stock was trading at $2.25 on January 1st, 2023. Since then, CPIX stock has decreased by 20.4% and is now trading at $1.7917. View the best growth stocks for 2023 here. When is Cumberland Pharmaceuticals' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024. View our CPIX earnings forecast. How were Cumberland Pharmaceuticals' earnings last quarter? Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX) issued its quarterly earnings data on Tuesday, November, 7th. The specialty pharmaceutical company reported $0.02 EPS for the quarter. The specialty pharmaceutical company earned $10.09 million during the quarter. Cumberland Pharmaceuticals had a negative net margin of 6.17% and a positive trailing twelve-month return on equity of 8.68%. What is A. J. Kazimi's approval rating as Cumberland Pharmaceuticals' CEO? 9 employees have rated Cumberland Pharmaceuticals Chief Executive Officer A. J. Kazimi on Glassdoor.com. A. J. Kazimi has an approval rating of 9% among the company's employees. This puts A. J. Kazimi in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of Cumberland Pharmaceuticals own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cumberland Pharmaceuticals investors own include Fulcrum Therapeutics (FULC), VIVUS (VVUS), CymaBay Therapeutics (CBAY), Sorrento Therapeutics (SRNE), SCYNEXIS (SCYX), VBI Vaccines (VBIV), Akero Therapeutics (AKRO), Cerecor (CERC), Xeris Biopharma (XERS). How do I buy shares of Cumberland Pharmaceuticals? Shares of CPIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:CPIX) was last updated on 12/31/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.